Valeo Pharma announces filing of a new drug submission for low molecular weight heparin in Canada

14 November 2019 - Valeo Pharma announced today that the new drug submission filed for a low molecular weight heparin ...

Read more →

'Incredibly upsetting': breast cancer patients dealing with shortage of common drug treatment

12 November 2019 - When Tricia Smith tried to fill her prescription for tamoxifen two weeks ago, she was shocked ...

Read more →

Xeomin Cosmetic licensed for additional indications In Canada

7 November 2019 - Merz Pharma has announced that Health Canada has provided marketing authorization for additional indications for Xeomin ...

Read more →

Janssen announces Health Canada approval of Imbruvica (ibrutinib) in combination with obinutuzumab for treatment naïve patients with chronic lymphocytic leukaemia

8 November 2019 - Patients experienced a 77% reduction in risk of disease progression or death compared to chlorambucil plus obinutuzumab. ...

Read more →

Endoceutics receives Health Canada approval for Intrarosa

6 November 2019 - The first innovative drug for the treatment of vulvovaginal atrophy with prasterone. ...

Read more →

Canadian ambassador says drug imports would not lower U.S. prices

2 November 2019 - Canada does not have a large enough supply of prescription drugs to meet U.S. demand, and ...

Read more →

Janssen announces Health Canada approval of Darzalex (daratumumab) in combination with lenalidomide and dexamethasone for newly diagnosed patients with multiple myeloma who are transplant ineligible

30 October 2019 - This Darzalex combination regimen reduced the risk of disease progression or death by 44% in newly ...

Read more →

Costly prescription eye treatment highlights a loophole in Canada’s drug-price regulation process

28 October 2019 - The Ontario government has begun covering $100,000-a-year eye drops for an ultrarare disease, bringing relief to ...

Read more →

It’s time for Canada to embrace universal pharmacare and protect drug coverage from corporate erosion

28 October 2019 - President Trump recently unveiled an executive order — originally titled “Protecting Medicare from Socialist Destruction” — ...

Read more →

Women living with metastatic breast cancer in British Columbia now have public access to Kisqali

23 October 2019 - Novartis Pharmaceuticals Canada is pleased to announce that British Columbia will now reimburse Kisqali (ribociclib) for eligible ...

Read more →

Knight Therapeutics and SIFI announce approval of Netildex in Canada

23 October 2019 - Knight Therapeutics and SIFI today announced that Health Canada has approved Netildex for the treatment of inflammatory ...

Read more →

Canadian election clears path for universal drug plan

23 October 2019 - Canada’s Liberal government is more likely to pass a universal prescription drug plan after losing its majority ...

Read more →

Patients in Quebec now have access to Dupixent for the treatment of moderate-to-severe atopic dermatitis

22 October 2019 - Quebec becomes the first province to list Dupixent for public reimbursement in adult patients. ...

Read more →

Which health care promises will the Liberals realistically be able to keep?

22 October 2019 - The Liberals have a number of significant health care-related campaign promises to live up to as ...

Read more →

Trump urges quicker action to allow imported drugs from Canada

22 October 2019 - U.S. President Donald Trump on Monday called on U.S. Health Secretary Alex Azar to speed up ...

Read more →